GV (Google Ventures)

Activity from announced rounds

Activity in this selectionUnited States · Sep 30, 2026 · Sep 1, 2026

GV invests in technology and life-science companies, including AI applications, developer tools, cybersecurity, computing infrastructure and healthcare.

Its AI interests span the stack: new computing systems and inference infrastructure, tools for developers, software for professional workflows and applications in drug discovery and patient care. This gives both infrastructure founders and application builders a route to a specialist investment team.

GV developed the design sprint, a five-day process that takes a business question through problem definition, prototyping and customer testing. Its published sprint materials help teams test demand and product decisions before committing to a full launch.

Sources
Rounds participated in
2
Confirmed lead rounds
1
All roles disclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$625M
2 disclosed · full round size, not this investor’s share

By stage

Series C+2

By primary sector

AI1
Biotech1

By country

United States2

Rounds

2 in this selection
Snorkel AI

Snorkel AI helps enterprises build expert-curated training data and benchmarks for advanced AI models and agents.

$350MSeries E
Participant
Encoded Therapeutics Inc.

Encoded develops precision gene therapies for neurological disorders, led by ETX101, a gene-regulation therapy for people with SCN1A-positive Dravet syndrome.

$275MSeries F
Lead